These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2526211)

  • 61. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2718-22. PubMed ID: 1680111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus.
    Pan Q; Gong L; Xiao H; Feng Y; Li L; Deng Z; Ye L; Zheng J; Dickerson CA; Ye L; An N; Yang C; Liu HF
    Front Immunol; 2017; 8():348. PubMed ID: 28396669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
    Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
    [TBL] [Abstract][Full Text] [Related]  

  • 65. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
    Jevnikar AM; Grusby MJ; Glimcher LH
    J Exp Med; 1994 Apr; 179(4):1137-43. PubMed ID: 7908320
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases.
    Izui S; Berney T; Shibata T; Fulpius T
    Ann Rheum Dis; 1993 Mar; 52 Suppl 1(Suppl 1):S48-54. PubMed ID: 8481059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis.
    Harper JM; Thiru S; Lockwood CM; Cooke A
    Eur J Immunol; 1998 Jul; 28(7):2217-26. PubMed ID: 9692891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
    Carlsten H; Tarkowski A
    Scand J Immunol; 1989 Oct; 30(4):457-62. PubMed ID: 2814366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice.
    Hortelano S; Díaz-Guerra MJ; Gonzalez-García A; Leonardo E; Gamallo C; Boscá L; Martínez-A C
    J Immunol; 1997 Feb; 158(3):1402-8. PubMed ID: 9013985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of cyclophosphamide pretreatment on defective delayed-type hypersensitivity in autoimmune-prone MRL mice.
    Okuyama H; Matsunaga T; Kobayashi S; Hashimoto Y; Kawaguchi Y; Yamamoto K
    Int Arch Allergy Appl Immunol; 1989; 88(4):394-401. PubMed ID: 2785972
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY
    J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice.
    Furukawa F; Kanauchi H; Wakita H; Tokura Y; Tachibana T; Horiguchi Y; Imamura S; Ozaki S; Takigawa M
    J Invest Dermatol; 1996 Jul; 107(1):95-100. PubMed ID: 8752846
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice.
    Kanauchi H; Imamura S; Takigawa M; Furukawa F
    J Dermatol; 1994 Dec; 21(12):935-9. PubMed ID: 7868765
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE
    J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.